Personal tools

FF:13075-140A6: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 1: Line 1:
{{f5samples
{{f5samples
|id=FF:13075-140A6
|ancestors_in_anatomy_facet=UBERON:0000061,UBERON:0000465,UBERON:0000479,UBERON:0001062,UBERON:0002384
|name=J2E erythroblastic leukemia response to erythropoietin, 06hr, biol_rep1
|sample_id=13075
|rna_tube_id=140A6
|rna_box=140
|rna_position=A6
|sample_cell_lot=
|sample_cell_catalog=
|sample_company=
|rna_lot_number=
|rna_catalog_number=
|sample_species=Mouse (Mus musculus)
|sample_strain=
|sample_dev_stage=
|sample_tissue=blood
|sample_donor(cell lot)=rep1
|sample_sex=
|sample_age=
|sample_ethnicity=
|rna_rin=
|rna_od260/230=2.58
|rna_od260/280=2.1
|sample_cell_type=erythroblast
|sample_cell_line=J2E
|sample_collaboration=Peter Klinken (Western Australian Institute of Medical Research)
|sample_experimental_condition=J2E erythroblastic leukemia response to erythropoietin
|sample_disease=
|rna_sample_type=
|rna_extraction_protocol=Repurified by minelute
|rna_weight_ug=18.64
|rna_concentration=1.86
|sample_note=
|profile_hcage=CNhs12453,LSID915,release011,COMPLETED
|profile_cagescan=,,,
|profile_srnaseq=,,,
|profile_rnaseq=,,,
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000034,CL:0000037,CL:0000038,CL:0000048,CL:0000049,CL:0000050,CL:0000063,CL:0000134,CL:0000144,CL:0000219,CL:0000255,CL:0000547,CL:0000548,CL:0000566,CL:0000723,CL:0000763,CL:0000764,CL:0000765,CL:0000837,CL:0000839,CL:0000988,CL:0002031,CL:0002032,CL:0002320,CL:0002371
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000034,CL:0000037,CL:0000038,CL:0000048,CL:0000049,CL:0000050,CL:0000063,CL:0000134,CL:0000144,CL:0000219,CL:0000255,CL:0000547,CL:0000548,CL:0000566,CL:0000723,CL:0000763,CL:0000764,CL:0000765,CL:0000837,CL:0000839,CL:0000988,CL:0002031,CL:0002032,CL:0002320,CL:0002371
|ancestors_in_anatomy_facet=UBERON:0000061,UBERON:0000465,UBERON:0000479,UBERON:0001062,UBERON:0002384
|ancestors_in_disease_facet=DOID:0050686,DOID:0060083,DOID:1240,DOID:14566,DOID:162,DOID:2531,DOID:4
|ancestors_in_disease_facet=DOID:0050686,DOID:0060083,DOID:1240,DOID:14566,DOID:162,DOID:2531,DOID:4
|sample_description=
|comment=
|created_by=
|creation_date=
|def=
|fonse_cell_line=FF:0101035
|fonse_cell_line=FF:0101035
|fonse_cell_line_closure=FF:0101035
|fonse_cell_line_closure=FF:0101035
Line 66: Line 33:
|fonse_treatment=EFO:0000369,FF:0000337,FF:0000510,FF:13075-140A6
|fonse_treatment=EFO:0000369,FF:0000337,FF:0000510,FF:13075-140A6
|fonse_treatment_closure=EFO:0000369,FF:0000337,FF:0000510,FF:13075-140A6
|fonse_treatment_closure=EFO:0000369,FF:0000337,FF:0000510,FF:13075-140A6
|top_motifs=
|comment=
|created_by=
|creation_date=
|def=
|has_quality=
|has_quality=
|id=FF:13075-140A6
|is_a=EFO:0002091;;FF:0000103;;FF:0000510
|is_a=EFO:0002091;;FF:0000103;;FF:0000510
|name=J2E erythroblastic leukemia response to erythropoietin, 06hr, biol_rep1
|namespace=FANTOM5
|namespace=FANTOM5
|part_of=
|part_of=
|profile_cagescan=,,,
|profile_hcage=CNhs12453,LSID915,release011,COMPLETED
|profile_rnaseq=,,,
|profile_srnaseq=,,,
|rna_box=140
|rna_catalog_number=
|rna_concentration=1.86
|rna_extraction_protocol=Repurified by minelute
|rna_lot_number=
|rna_od260/230=2.58
|rna_od260/280=2.1
|rna_position=A6
|rna_rin=
|rna_sample_type=
|rna_tube_id=140A6
|rna_weight_ug=18.64
|sample_age=
|sample_cell_catalog=
|sample_cell_line=J2E
|sample_cell_lot=
|sample_cell_type=erythroblast
|sample_collaboration=Peter Klinken (Western Australian Institute of Medical Research)
|sample_company=
|sample_description=
|sample_dev_stage=
|sample_disease=
|sample_donor(cell lot)=rep1
|sample_ethnicity=
|sample_experimental_condition=J2E erythroblastic leukemia response to erythropoietin
|sample_id=13075
|sample_note=
|sample_sex=
|sample_species=Mouse (Mus musculus)
|sample_strain=
|sample_tissue=blood
|top_motifs=
}}
}}

Revision as of 15:26, 21 March 2012


Name:J2E erythroblastic leukemia response to erythropoietin, 06hr, biol_rep1
Species:Mouse (Mus musculus)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainNA
tissueblood
dev stageNA
sexNA
ageNA
cell typeerythroblast
cell lineJ2E
companyNA
collaborationPeter Klinken (Western Australian Institute of Medical Research)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot numberNA
catalog numberNA
sample typeNA
extraction protocol (Details)Repurified by minelute
Download raw sequence, BAM & CTSS
Mm9
BAMCTSS
[{{{mm9bam}}} download][{{{mm9ctss}}} donwload]
Mm10
BAMCTSS
[{{{mm10bam}}} download][{{{mm10ctss}}} donwload]





Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data

CNhs12453



Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample

JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12453This sample isn't target for the analysis

FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12453This sample isn't target for the analysis

de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br> library id: CNhs12453


FANTOM5 (FF) ontology

Direct parent terms


Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data

CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000034 (stem cell)
0000037 (hematopoietic stem cell)
0000038 (erythroid progenitor cell)
0000048 (multi fate stem cell)
0000049 (common myeloid progenitor)
0000050 (megakaryocyte-erythroid progenitor cell)
0000134 (mesenchymal cell)
0000219 (motile cell)
0000255 (eukaryotic cell)
0000547 (proerythroblast)
0000548 (animal cell)
0000566 (angioblastic mesenchymal cell)
0000723 (somatic stem cell)
0000763 (myeloid cell)
0000764 (erythroid lineage cell)
0000765 (erythroblast)
0000837 (hematopoietic multipotent progenitor cell)
0000839 (myeloid lineage restricted progenitor cell)
0000988 (hematopoietic cell)
0002031 (hematopoietic lineage restricted progenitor cell)
0002032 (hematopoietic oligopotent progenitor cell)
0002320 (connective tissue cell)
0002371 (somatic cell)

DOID: Disease
0050686 (organ system cancer)
0060083 (immune system cancer)
1240 (leukemia)
14566 (disease of cellular proliferation)
162 (cancer)
2531 (hematologic cancer)
4 (disease)

UBERON: Anatomy
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000479 (tissue)
0001062 (anatomical entity)
0002384 (connective tissue)

FF: FANTOM5
NA

Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=FF:13075-140A6&oldid=728352"